Reported Usona Psilocybin FDA Filing Shifts Attention to Treatment Readiness
As the first potential FDA approval of psilocybin approaches, psychedelic care providers are preparing for questions of patient access, clinical capacity, and reimbursement. November…
Read More
Latest Articles
Do Different Psychedelics Affect Different Brain Circuits?
November 3, 2026
Fine-Tuning rTMS to Target Persistent Tinnitus
November 2, 2026
Ketamine’s Effects on Sleep and Mood May Differ
November 1, 2026
TMS Falls Short of Sham in Borderline Personality Disorder Trial
October 31, 2026
Can a New ECT Approach Reduce Memory Side Effects?
October 30, 2026
Get the Mental Health Breakthroughs
No One Else Is Talking About
Every week, we deliver the latest news, research, and real-world updates from the frontlines of interventional psychiatry.
Join the IPN Newsletter
Reach out for guest article or sponsorship opportunities
Interested in collaborating with us?
Share your details, and let’s explore how we can work together to create meaningful experiences for our audience.